Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, is showcasing its latest medical innovations at this year's Arab Health exhibition, the biggest medical exhibition in the Middle East, in Dubai at booths S1 F30 and Z4 H10 from Jan 25 to 28.
Mindray is exhibiting the latest devices from its three key business lines, namely Patient Monitoring and Life Support, In-Vitro Diagnostics, and Medical Imaging System.
One of the highlights is BeneVision N22 Patient Monitor. The world’s first rotatable bedside patient monitor makes its first official appearance in a major exhibition to audiences in the Middle East and Africa. This revolutionary model is designed to optimize user experience with an extra-large touchscreen, a rotatable landscape with portrait layouts, an ultra slim profile, and plug-and-play modules. BeneVision N22 also features cutting-edge measurements such as INVOS rSO2, ICG, PiCCO, AG, RM, BIS, NMT and support tools such as HemoSight™ and ST Graphic™ to help enhance diagnostic confidence. The iView clinical informatics workstation and BeneLink platform improve the efficiency of information flow.
At Arab Health's co-event Medlab, Mindray’s to-be-released chemistry analyzer, BS-240, makes its debut and attracts much attention at Booth Z4 H10. A result of Mindray’s innovative technology and profound expertise in lab chemistry, BS-240 provides an enhanced diagnostic solution tailor-made for middle to small laboratories. Visitors are also interested to see the CL-1000i Chemiluminescence Immunoassay System. CL-1000i is a state-of-the-art benchtop system for immunoassay tests with enhanced enzymatic chemiluminescence technology. With a throughput of 120 tests per hour, CL-1000i provides a large reagent and sample capacity, reliable performance and a user-friendly operation interface. Simple yet robust, CL-1000i is well-suited for small and mid-sized laboratories.
Mindray's two freshly launched medical imaging systems are also exhibited at this year's Arab Health. Resona 7 Diagnostic Ultrasound System attracts great attention from the audience. The premium system is designed to meet the demanding challenges in clinicians’ daily diagnosis and researching interests. As a result of the cross-Pacific cooperation between Mindray and Zonare (a Mindray company), Resona 7 has kick-started a new era for Mindray’s ultrasound business. Powered by the revolutionary ZONE Sonography®Technology, Resona 7’s new ZST+ platform brings image quality to a higher level with zone acquisition and channel data processing. Resona 7 also provides useful tools for clinical research, such as V Flow for vascular hemodynamics evaluation and Smart Planes™, which allows for intelligent plane acquisition from a 3D dataset for fetal central nervous system diagnosis.
MobiEye 700 Mobile Digital Radiography System impresses visitors with its prolonged power and intelligent mobility. A fully charged MobiEye 700 can expose up to 700 times, drive 70 kilometers, and operate for seven days. Its unique bionic manipulator provides maximum clinical coverage. With its zero dead-angle rotation capability, the system is suitable for handling the complex hospital environment.
“Mindray strives to share the latest medial innovations with the world. In today’s extremely dynamic healthcare industry, our mission is to reach forward and provide customers with specialized and localized solutions empowered by the most cutting edge technologies.” said Richard Yang, Vice President of Mindray International Sales and Marketing. Arab Health is the second largest healthcare exhibition and congress in the world and the largest in the Middle East. The 2016 exhibition showcases more than 4,000 companies exhibiting their latest innovations to more than 130,000 healthcare professionals attending from 163 countries. It offers important opportunities for Mindray to share its latest progresses and achievements in medical technologies with the world.